High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation

Transplant International

Volumn 22, Issue 6, 2009, Pages 622-625

  Alfadhli, Eman ^b   Koh, Angela ^b   Albaker, Waleed ^b   Bhargava, Ravi ^b   Ackerman, Thomas ^b   McDonald, Charlotte ^b   Ryan, Edmond A ^b   Shapiro, A M James ^b   Senior, Peter A ^a,b  

^a University of Alberta ^*  (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Islet transplantation; Ovarian cyst; Sirolimus; Tacrolimus

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; ECHOGRAPHY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVARY CYST; PANCREAS ISLET TRANSPLANTATION; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ABDOMEN; ADULT; CANADA; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; OVARIAN CYSTS; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 65549113459     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00839.x     Document Type: Article

References (14)

1. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060. (Pubitemid 40911269)
2. Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol 1999 13 : 345. (Pubitemid 29312644)
3. Hilger WS, Magrina JF, Magtibay PM. Laparoscopic management of the adnexal mass. Clin Obstet Gynecol 2006 49 : 535. (Pubitemid 44181426)
4. Vaughan R, Henderson SC, Rahatzad M, Barry J. Unsuspected adnexal masses in renal transplant recipients. J Urol 1982 128 : 1017. (Pubitemid 13211658)
5. Gaber AO, Kahan BD, Van Buren C, et al. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Transplantation 2008 86 : 1187.
6. Cure P, Pileggi A, Froud T, et al. Alterations of the female reproductive system in recipients of islet grafts. Transplantation 2004 78 : 1576. (Pubitemid 39648428)
7. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230. (Pubitemid 30490390)
8. Erickson GF, Schreiber JR. Morphology and physiology of the ovary. In : Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia, PA : Lippincott Williams Wilkins, 2001 : 918 934.
9. Kirken RA, Wang YL. Molecular actions of sirolimus: sirolimus and mTor. Transplant Proc 2003 35 : 227S. (Pubitemid 36547948)
10. Seufferlein T, Rozengurt E. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res 1996 56 : 3895. (Pubitemid 26284735)
11. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, et al. Menstrual cycle and sex hormone profile in perimenopausal women after liver transplantation. Transplant Proc 2006 38 : 2909.
12. Pietrzak B, Cyganek A, Jabiry-Zieniewicz Z, et al. Function of the ovaries in female kidney transplant recipients. Transplant Proc 2006 38 : 180. (Pubitemid 43303631)
13. Tondolo V, Citterio F, Panocchia G, et al. Gonadal function and immunosuppressive therapy after renal transplantation. Transplant Proc 2005 37 : 1915. (Pubitemid 40790868)
14. Berney T, Secchi A. Rapamycin in islet transplantation: friend or foe? Transpl Int 2008 22 : 153.